Anti-Profiteering allegation: CCI Directs DGAP to Re-investigate S.R. Lifesciences

Dr. Meenakshi Agrawal Vs M/s. S.R. Lifesciences (Competition Commission of India)

The Competition Commission of India (CCI) has issued a directive to the Director General of Anti-Profiteering (DGAP) to conduct a further investigation into allegations of anti-profiteering against S.R. Lifesciences and its two suppliers. The allegations, brought forth by Dr. Meenakshi Agrawal, concern the respondents’ failure to pass on the benefits of a GST rate reduction to the consumers.

Analysis: T

Please become a Premium member. If you are already a Premium member, login here to access the full content.